The global point-of-care molecular diagnostics is increasingly advancing to meet the challenges of emerging and re-emerging infections. Point of care testing is essential for the rapid discovery of analytes in a patient and/or sample, hence enabling enhanced disease detection, monitoring and management. POC molecular testing and other devices improve the standard of care by combining quick diagnosis with treatment decision. Based on technology, the PoC molecular diagnostics has been categorized into PCR-based, genetic sequencing-based, hybridization-based, and microarray-based tests and devices.NiiN linked laboratory uses kinematic automation for lateral flow tests, lateral flow assays, test strips, rapid diagnostic tests, immunoassays, medical device assembly, cartridge and cassette assembly.
NiiN intends to develop and advance new generation of rapid test kits to support healthcare delivery.